Literature DB >> 28418445

Decision Making in Adrenoleukodystrophy: When Is a Good Outcome Really a Good Outcome?

Keith Van Haren1, Marc Engelen2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28418445      PMCID： PMC7959815          DOI： 10.1001/jamaneurol.2017.0095

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  16 in total

Review 1.  Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders.

Authors:  Shalini Shenoy; Jaap J Boelens
Journal:  Curr Opin Pediatr       Date:  2015-02       Impact factor: 2.856

2.  Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening.

Authors:  L Bezman; A B Moser; G V Raymond; P Rinaldo; P A Watkins; K D Smith; N E Kass; H W Moser
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

3.  Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation.

Authors:  P Aubourg; S Blanche; I Jambaqué; F Rocchiccioli; G Kalifa; C Naud-Saudreau; M O Rolland; M Debré; J L Chaussain; C Griscelli
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

4.  Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.

Authors:  Weston P Miller; Steven M Rothman; David Nascene; Teresa Kivisto; Todd E DeFor; Richard S Ziegler; Julie Eisengart; Kara Leiser; Gerald Raymond; Troy C Lund; Jakub Tolar; Paul J Orchard
Journal:  Blood       Date:  2011-05-17       Impact factor: 22.113

5.  Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.

Authors:  Elizabeth I Pierpont; Julie B Eisengart; Ryan Shanley; David Nascene; Gerald V Raymond; Elsa G Shapiro; Rich S Ziegler; Paul J Orchard; Weston P Miller
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

6.  Predictors of quality of life in patients with refractory mesial temporal lobe epilepsy.

Authors:  Carla Pauli; Maria Emilia de Oliveira Thais; Lucia Sukys Claudino; Maria Alice Horta Bicalho; Alexandre Cunha Bastos; Ricardo Guarnieri; Jean Costa Nunes; Katia Lin; Marcelo Neves Linhares; Roger Walz
Journal:  Epilepsy Behav       Date:  2012-09-30       Impact factor: 2.937

7.  Bone marrow transplant in adrenoleukodystrophy.

Authors:  H W Moser; P J Tutschka; F R Brown; A E Moser; A M Yeager; I Singh; S A Mark; A A Kumar; J M McDonnell; C L White
Journal:  Neurology       Date:  1984-11       Impact factor: 9.910

8.  Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study.

Authors:  Björn M van Geel; Bwee Tien Poll-The; Aad Verrips; Jaap-Jan Boelens; Stephan Kemp; Marc Engelen
Journal:  J Inherit Metab Dis       Date:  2014-12-09       Impact factor: 4.982

9.  Adrenoleukodystrophy: a scoring method for brain MR observations.

Authors:  D J Loes; S Hite; H Moser; A E Stillman; E Shapiro; L Lockman; R E Latchaw; W Krivit
Journal:  AJNR Am J Neuroradiol       Date:  1994-10       Impact factor: 3.825

10.  Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study.

Authors:  Asif Mahmood; Gerald V Raymond; Prachi Dubey; Charles Peters; Hugo W Moser
Journal:  Lancet Neurol       Date:  2007-08       Impact factor: 44.182
View more
  1 in total

1.  Post-transplant adaptive function in childhood cerebral adrenoleukodystrophy.

Authors:  Elizabeth I Pierpont; Erin McCoy; Kelly E King; Rich S Ziegler; Ryan Shanley; David Nascene; Gerald V Raymond; Rachel Phelan; Troy C Lund; Paul J Orchard; Weston P Miller
Journal:  Ann Clin Transl Neurol       Date:  2018-01-22       Impact factor: 4.511
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.